Abstract
This report:
- Analyzes adult and embryonic stem cell technology, applications (current
and future), as well as the impact of stem cell focused products and services
on healthcare markets and beyond.
- Provides quantitative market forecasts for near term applications and
documents trends that impact product demand. Segments markets by both
technology and application.
- Covers the latest stem cell research and commercialization advances with
implications for end users such as the healthcare market as well as the
biotechnology, and pharmaceutical markets.
- Includes impact of stem cells in biotech for products such as stem cell
derived protein products, diagnostic related stem cell technology, and stem
cell banking. Additionally, the current and future impact of stem cell
technology in the research and development of pharmaceuticals through the use
of disease specific stem cell lines and cancer stem cells is included.
- Provides complete company profiles, competitive analysis, industry
structure, market shares, and patent analyses
INTRODUCTION
Study goals and objectives
BCC' s goal in conducting this study was to determine the current status of
stem cell technology and its applications and assess its growth potential over
a 5-year period from 2007 to 2012. We are particularly interested in the
position of adult stem cell technology and applications as compared to the
development and applications of embryonic stem cells. Additionally, we are
interested in the market potential of emerging breakthroughs in stem cell
research such as induced pluripotent stem cells (iPS).
Our key objective is to present a comprehensive analysis of the current state
of stem cell research and development (R&D) as well as the current stem cell
market and its future direction.
Reasons for doing the study
Stem cell technology has been described as the next revolution in medicine.
Therapeutic stem cell applications have been proposed to address a wide range
of health care needs. We are interested in determining the current state of
stem cell technology, where stem cells are currently being applied, and
evaluating the potential growth for stem-cell-based applications. In
particular, we are interested in discerning the current technological state
and potential growth of adult stem-cell-based applications as compared to
embryonic-stem-cell-based applications. Additionally, we are interested in
looking forward to emerging advancements in stem cell technology and
evaluating the potential impact these advancements could have on the
development of stem-cell-based products.
Scope of report
This report encompasses the two major classes of stem cells: adult and
embryonic. BCC examined the current state of stem cell technology, focusing on
these two major classes as well as emerging breakthroughs in stem cell
research and development. Further, BCC evaluated the current stem cell market
in the United States (U.S.) and examined the future impact of stem-cell-based
technology, presenting forecasts of growth over the next 5 years.
Technological issues covering current and emerging stem-cell-based therapeutic
applications are also reviewed. Further issues considering stem-cell-based
therapeutic research and development and its applications are additionally
discussed.
Given the major role that the U.S. plays in the world health care market (both
as provider and consumer), this analysis is focused predominantly on the
current state of stem cell technology and its applications in the U.S., with
some discussion regarding worldwide stem cell technology impact. In addition
to technological considerations as well as market issues, we examine
governmental (legal and political) as well as social issues regarding the
research and development of stem-cell-based therapeutic applications. The
present and projected status of stem-cell-based technology is compared for
high value applications of cellular therapeutics, engineered tissue for
transplantation, and therapeutic stem cell banking. Further, the present and
projected status of stem-cell-based therapeutic research applications are
projected for high value applications such as cell-based assays, diagnostic
tools, and necessary support reagents and materials.
Intended audience
Given the broad application potential of stem-cell-based technology, the
present study will be of interest to the life science industry, in particular,
to individuals in the biotechnology, pharmaceutical, and medical device
markets. Further, it will be of interest to manufacturers of reagents and
tools that support the research and development of stem-cell-based products
and services.
Further, this report will of be of interest to professionals presently focused
in areas of stem cell research, development, and commercialization as well as
those surveying potential stem-cell-based opportunities for investment.
Additionally, this report will be of particular interest to health care
professionals surveying the potential therapeutic application of
stem-cell-based technology and its growth.
Information Sources
BCC surveyed approximately 60 companies directly and actively engaged in stem
cell focused research and product development to obtain data for this study.
Contained within this study are companies pursuing both adult stem-cell-based
products as well as embryonic-based stem cell applications. Of particular
focus are companies centered on the development of cellular therapeutics,
engineered tissue for transplantations, and therapeutic banking of stem cells
for future medical applications. Also surveyed were academic stem cell
researchers as well as life science industry professionals. Additionally,
extensive data was compiled from primary scientific source literature and
current financial and trade information as well as government and regulatory
sources, both federal and state.
| 
View Cart
